Response.

Frantz, Robert P; Zhao, Carol; Farber, Harrison W; Badesch, David B; Elliott, C Greg; Frost, Adaani E; McGoon, Michael D; Mink, David R; Selej, Mona; Benza, Raymond L

Response.

Frantz, Robert P; Zhao, Carol; Farber, Harrison W; Badesch, David B; Elliott, C Greg; Frost, Adaani E; McGoon, Michael D; Mink, David R; Selej, Mona; Benza, Raymond L.

Affiliation

Frantz RP; Mayo Clinic, Rochester, MN. Electronic address: frantz.robert@mayo.edu.
Zhao C; Actelion Pharmaceuticals US, Inc. South, San Francisco, CA.
Farber HW; Pulmonary Center, Boston University School of Medicine, Boston, MA.
Badesch DB; University of Colorado, Denver, CO.
Elliott CG; Intermountain Medical Center and the University of Utah School of Medicine, Salt Lake City, UT.
Frost AE; Houston Methodist Lung Cancer, Weill Cornell Medical College, Houston, TX.
McGoon MD; Mayo Clinic, Rochester, MN.
Mink DR; former employee of ICON Clinical Research.
Selej M; Actelion Pharmaceuticals US, Inc. South, San Francisco, CA.
Benza RL; Allegheny General Hospital, Pittsburgh, PA.

Chest ; 154(5): 1262-1264, 2018 11.

Article de En | MEDLINE | ID: mdl-30409362

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptide natriurétique cérébral Limites: Humans Langue: En Journal: Chest Année: 2018 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google